Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF
Mishal Khan, President VFAHT-FMC at Infection Prevention and Control Foundation and Vice President FMC LC at IFMSA-Pakistan, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Arrhythmia, adding:
“Excited to share our latest publication in the Journal of Arrhythmia:
‘Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database’
Using over two decades of national mortality data, our study is among the first to characterize long-term mortality trends and demographic disparities in patients with pulmonary embolism (PE) and coexisting atrial fibrillation (AF).
We found that PE-related mortality in patients with AF has risen significantly since 2009, with disproportionately higher mortality among men, rural populations, and certain geographic regions.
These findings highlight important inequities in cardiovascular outcomes and identify populations that may benefit from targeted prevention and healthcare interventions.
Beyond describing trends, our work provides a foundation for future research exploring the drivers of these disparities, including anticoagulation access and adherence, healthcare infrastructure, and socioeconomic factors.
It also supports the need for policies that strengthen AF screening, improve access to specialized cardiovascular care in underserved regions, and expand telemedicine-based anticoagulation management.
Grateful to all my co-authors for their incredible collaboration throughout this project.”
Title: Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database
Authors: Eeman Ahmad, Mishal Khan, Muhammad Ans, Hoor Ul Ain, Ahmad Qaisar, Shahzaib Ahmed, Olivier Uwishema, Ibrahim Nagmeldin Hassan, Muhammad Saad, Abbas Hayat Mallick, M Chadi Alraies

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:41Jens Helby: Long-Term Outcomes of Incidentally Detected Thrombocytopenia
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI